Man Group’s Standard BioTools LAB Stock Holding History

Man Group’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$611K	Buy	+742,793	New	+$702K	﹤0.01%	2003
2024 Q3	–	Sell	-12,913	Closed	-$22.9K	–	2094
2024 Q2	$22.9K	Sell	12,913 -297,691	-96%	-$728K	﹤0.01%	1988
2024 Q1	$842K	Buy	310,604 +112,424	+57%	+$271K	﹤0.01%	1612
2023 Q4	$438K	Buy	+198,180	New	+$423K	﹤0.01%	1718
2022 Q1	–	Sell	-21,100	Closed	-$83K	–	2272
2021 Q4	$83K	Sell	21,100 -35,800	-63%	-$168K	﹤0.01%	1889
2021 Q3	$375K	Buy	+56,900	New	+$374K	﹤0.01%	1600
2019 Q2	–	Sell	-13,295	Closed	-$177K	–	1948
2019 Q1	$177K	Buy	+13,295	New	+$140K	﹤0.01%	1888

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Man Group's LAB Position: Q2 2026 in Review

Man Group opened a new position in Standard BioTools (LAB) in Q2 2026: 742,793 shares worth $611K. The stake represents ﹤0.01% of the portfolio and ranks #2003 among its holdings. This is a return to the name: Man Group previously reported a position in LAB as recently as Q2 2024.

Man Group first reported a position in LAB in Q1 2019 and has held it in 7 quarters since. The position peaked at $842K in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Man Group held 742,793 shares of Standard BioTools worth $611K as of Q2 2026.
Standard BioTools was a new Man Group position in Q2 2026.
Standard BioTools made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2003 holding.
Man Group first reported a position in Standard BioTools in Q1 2019 and has held it in 7 quarters since.
Man Group's Standard BioTools position peaked at $842K in Q1 2024.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.